Atlas Trials

Randomized Trial Standard of Care Vascular Access Strategies for (Neo)Adjuvant Trastuzumab-based Breast Cancer Treatment.

Clinical trial NCT02632435 · COMPLETED

Trial details

NCT number
NCT02632435
Sponsor
Ottawa Hospital Research Institute
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast CancerCancer
Start date
2016-04-01
Primary completion
2019-05-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.